The Company is a development stage Company.


Updates from The Motley Fool

Latest updates on Delcath Systems from Fool.com.
5 Reasons Not to Worry This Week

It's not a perfect world out there for investors, but things may be starting to get better. Last ...

Why Did My Stock Just Die?

The markets reversed course again, but your stock took an even bigger nosedive. Don't panic. Firs...

Delcath Wants a Do-Over

You'd think a drug failing to show an effect would be the worst thing that could happen to a biot...

Delcath's Disappointing Delay

I'm a little surprised at how well Delcath Systems ( Nasdaq: DCTH     ) is holding up today. ...

These Cold Stocks Are Heating Up

When a stock's share price is lower than a North Dakota thermometer in February, investors tend t...

Tomorrow's Monster Stock?

Stocks climbing to 10 times their original price are rare breeds -- but they're not impossible to...

The New Biotech Binary Event

The Food and Drug Administration seems to be giving out more "refuse to file" letters these days ...

Is Delcath a Bad News Buy?

Medical-device developer Delcath Systems ( Nasdaq: DCTH     ) dropped a whopping 38% yesterda...

Why Did My Stock Just Die?

Your stock just took a nosedive -- but don't panic. First, let's see whether it had good reason t...

Rocket Stock or Dud?

"The bigger they are, the harder they fall." It's the worst nightmare of every investor in today'...

Tomorrow's Monster Stock?

Stocks climbing to 10 times their original price are rare breeds -- but they're not impossible to...

Wall Street's Buy List

Actions speak louder than words, as the old saying goes. So why does the media focus so much atte...

Wall Street's Best Hidden Stocks

When asked for the secret of his success, baseball player Wee Willie Keeler replied, "Hit 'em whe...

Rocket Stock or Dud?

"The bigger they are, the harder they fall." It's the worst nightmare of every investor in today'...



Stock Performance

View Interactive DCTH Charts
Sponsored by

Key Data Points

Primary metrics and data points about Delcath Systems.
Current Price: $1.98
Prev Close: $1.97
Open: $1.95
Bid: $1.93
Ask: $2.00
Day's Range: $1.91 - $2.03
52wk Range: $1.35 - $9.60
Volume: 46,093
Avg Vol 249,418
Market Cap: $43M
P/E (ttm): -0.19
EPS (ttm): ($10.19)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Delcath Systems.
CAPS Rating 1 out of 5
 
122 Outperform
30 Underperform
CAPS All Stars
 
11 Outperform
14 Underperform

How do you think Delcath Systems will perform against the market?



You pick for Delcath Systems is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Eamonn P. Hobbs, CEO

0% Approve

Based on 3 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Delcath Systems.

The Company is a development stage Company.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers